M.A. Choti

983 total citations
29 papers, 738 citations indexed

About

M.A. Choti is a scholar working on Hepatology, Oncology and Surgery. According to data from OpenAlex, M.A. Choti has authored 29 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in M.A. Choti's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). M.A. Choti is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). M.A. Choti collaborates with scholars based in United States, France and South Korea. M.A. Choti's co-authors include Eric K. Nakakura, Elliot K. Fishman, David A. Bluemke, Philippe Soyer, Brian S. Kuszyk, Bruce A. Urban, James V. Sitzmann, Ralph H. Hruban, Gábor Fichtinger and Emad M. Boctor and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and American Journal of Roentgenology.

In The Last Decade

M.A. Choti

28 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Choti United States 13 284 212 179 178 144 29 738
Martin Krüger Germany 14 354 1.2× 223 1.1× 145 0.8× 319 1.8× 158 1.1× 26 1.1k
T. Kirchhoff Germany 17 249 0.9× 305 1.4× 102 0.6× 245 1.4× 104 0.7× 35 872
Dejiang Yu China 10 420 1.5× 208 1.0× 130 0.7× 175 1.0× 143 1.0× 20 697
Kevin P. Charpentier United States 16 130 0.5× 249 1.2× 345 1.9× 106 0.6× 200 1.4× 47 946
Qiyu Zhao China 15 188 0.7× 135 0.6× 113 0.6× 189 1.1× 105 0.7× 59 593
Tiffany Hennedige Singapore 16 267 0.9× 186 0.9× 148 0.8× 185 1.0× 152 1.1× 33 658
Lukas Philipp Beyer Germany 21 470 1.7× 224 1.1× 123 0.7× 217 1.2× 212 1.5× 80 1.3k
Bassam I. Aswad United States 17 129 0.5× 315 1.5× 94 0.5× 144 0.8× 361 2.5× 36 972
Wolfgang Hofgartner United States 13 222 0.8× 139 0.7× 76 0.4× 219 1.2× 76 0.5× 18 639

Countries citing papers authored by M.A. Choti

Since Specialization
Citations

This map shows the geographic impact of M.A. Choti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Choti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Choti more than expected).

Fields of papers citing papers by M.A. Choti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Choti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Choti. The network helps show where M.A. Choti may publish in the future.

Co-authorship network of co-authors of M.A. Choti

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Choti. A scholar is included among the top collaborators of M.A. Choti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Choti. M.A. Choti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mokdad, Ali H., Hong Zhu, Titus Augustine, et al.. (2017). Neoadjuvant chemotherapy versus chemoradiotherapy for resectable pancreatic head adenocarcinoma: a propensity score matched analysis. HPB. 19. S28–S28. 1 indexed citations
2.
Hyder, Omar, Matthew J. Weiss, Christopher L. Wolfgang, et al.. (2013). Post-Treatment Surveillance of Patients With Colorectal Liver Metastases: Does Intensity of Follow-up Imaging Impact Outcomes. Journal of Surgical Research. 179(2). 192–192. 1 indexed citations
4.
Ang, C., Alan P. Venook, M.A. Choti, et al.. (2011). Clinical/pathologic features and survival of patients with fibrolamellar-hepatocellular carcinoma (FLL-HCC): Data from the Fibrolamellar-Hepatocellular (FLL-HCC) Consortium.. Journal of Clinical Oncology. 29(15_suppl). 4089–4089. 1 indexed citations
5.
Reyes, Diane K., Nilofer S. Azad, Ayman Koteish, et al.. (2011). Abstract No. 4: Phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: Interim efficacy analysis. Journal of Vascular and Interventional Radiology. 22(3). S4–S5. 2 indexed citations
6.
Reyes, Diane K., Josephina A. Vossen, Ihab R. Kamel, et al.. (2010). Abstract No. 142: Single centre phase II trial of transarterial chemoembolization with drug eluting beads for patients with unresectable hepatocellular carcinoma: Initial experience in the USA. Journal of Vascular and Interventional Radiology. 21(2). S56–S56. 1 indexed citations
7.
Davidoff, Amy J., E. Onukwugha, James F. Gardner, et al.. (2008). Effect of age on survival benefit of adjuvant chemotherapy in elderly stage III colon cancer patients: a population-based analysis. Journal of Clinical Oncology. 26(15_suppl). 4014–4014. 2 indexed citations
8.
Diehl, Frank, Kerstin Schmidt, M.A. Choti, et al.. (2008). Circulating tumor DNA as a cancer biomarker. Journal of Clinical Oncology. 26(15_suppl). 4122–4122.
9.
Sicklick, Jason K. & M.A. Choti. (2005). Controversies in the Surgical Management of Cholangiocarcinoma and Gallbladder Cancer. Seminars in Oncology. 32(6 Suppl 9). 112–117. 7 indexed citations
10.
Patriciu, Alexandru, Michael M. Awad, Stephen B. Solomon, et al.. (2005). Robotic Assisted Radio-Frequency Ablation of Liver Tumors – Randomized Patient Study. Lecture notes in computer science. 8(Pt 2). 526–533. 28 indexed citations
11.
Kannangai, Rajesh, Ernesto P. Molmenti, Andreas Klein, et al.. (2004). Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. Journal of Viral Hepatitis. 11(4). 297–301. 37 indexed citations
13.
Boctor, Emad M., Gregory S. Fischer, M.A. Choti, Gábor Fichtinger, & Russell H. Taylor. (2004). A dual-armed robotic system for intraoperative ultrasound guided hepatic ablative therapy: a prospective study. 2517–2522 Vol.3. 41 indexed citations
14.
Nakakura, Eric K. & M.A. Choti. (2000). Management of hepatocellular carcinoma.. PubMed. 14(7). 1085–98; discussion 1098. 115 indexed citations
16.
Soyer, Philippe, et al.. (1997). Intraoperative and laparoscopic sonography of the liver. European Radiology. 7(8). 1296–1302. 8 indexed citations
17.
Kuszyk, Brian S., M.A. Choti, Bruce A. Urban, et al.. (1996). Hepatic tumors treated by cryosurgery: normal CT appearance.. American Journal of Roentgenology. 166(2). 363–368. 22 indexed citations
18.
Kuszyk, Brian S., David A. Bluemke, Bruce A. Urban, et al.. (1996). Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.. American Journal of Roentgenology. 166(1). 91–95. 109 indexed citations
19.
Soyer, Philippe, David A. Bluemke, M.A. Choti, & Elliot K. Fishman. (1995). Variations in the intrahepatic portions of the hepatic and portal veins: findings on helical CT scans during arterial portography.. American Journal of Roentgenology. 164(1). 103–108. 79 indexed citations
20.
Heath, David G., Philippe Soyer, Brian S. Kuszyk, et al.. (1995). Three-dimensional spiral CT during arterial portography: comparison of three rendering techniques.. Radiographics. 15(4). 1001–1011. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026